Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences in thromboxane A2 synthesis by megakaryocytes and platelets.

C M Wojenski1, P K Schick

  • 1Cardeza Foundation for Hematologic Research, Department of Medicine, Thomas Jefferson Medical College, Philadelphia, PA 19107-5099.

The Journal of Laboratory and Clinical Medicine
|October 1, 1991
PubMed
Summary

Megakaryocytes can synthesize thromboxane A2 early in maturation. However, platelet responsiveness to thrombin and collagen for thromboxane A2 synthesis is fully developed later.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Critical analysis of a computer-assisted tutorial on ECG interpretation and its ability to determine competency.

Medical teacher·2008
Same author

Integrins involved in the adhesion of megakaryocytes to fibronectin and fibrinogen.

Blood·1998
Same author

Synthesis and secretion of von Willebrand factor and fibronectin in megakaryocytes at different phases of maturation.

Arteriosclerosis, thrombosis, and vascular biology·1997
Same author

The synthesis and localization of alternatively spliced fibronectin EIIIB in resting and thrombin-treated megakaryocytes.

Blood·1996
Same author

The acylation of megakaryocyte proteins: glycoprotein IX is primarily myristoylated while glycoprotein Ib is palmitoylated.

Blood·1996
Same author

Fibronectin isoforms in megakaryocytes.

Stem cells (Dayton, Ohio)·1996

Area of Science:

  • Hematology
  • Biochemistry
  • Cell Biology

Background:

  • Thromboxane A2 (TXA2) is a potent platelet activator and vasoconstrictor.
  • Megakaryocytes are precursors to platelets, and their maturation involves significant cellular and functional changes.

Purpose of the Study:

  • To investigate the capacity for thromboxane A2 synthesis during megakaryocyte maturation.
  • To compare TXA2 synthesis in megakaryocytes and platelets in response to various stimuli.

Main Methods:

  • Isolated megakaryocytes (unseparated and staged) and washed platelets were used.
  • TXA2 synthesis was measured in response to arachidonic acid, calcium ionophore A23187, thrombin, and collagen.
  • Comparisons were normalized to equal amounts of cell protein.

Related Experiment Videos

Main Results:

  • Megakaryocytes and platelets showed similar TXA2 synthesis from exogenous arachidonic acid and endogenous sources stimulated by A23187.
  • Platelets exhibited significantly higher TXA2 synthesis in response to thrombin and collagen compared to megakaryocytes.
  • TXA2 synthesis capacity was present in immature megakaryocytes but not fully developed in the most immature cells.

Conclusions:

  • The ability to metabolize arachidonic acid for TXA2 synthesis is established early in megakaryocyte maturation.
  • Enhanced responsiveness to thrombin and collagen for TXA2 production is a feature that develops fully during platelet formation.